As an innovative foreign trade service provider driven by both technology transformation and foreign trade business, HiSiaddi has built a "1+2+3+4=1" service system and can supply vitamin B12 (cyanocobalamin) from multiple well-known original manufacturers. As a tech-driven foreign trade enterprise, HiSiaddi has repeatedly proposed formula optimization plans and application improvement suggestions for vitamin B12 (cyanocobalamin) products through technological transformation cooperation with manufacturers and precise insight into market demands. Below is a case of HiSiaddi’s formula optimization consulting services for vitamin B12 (cyanocobalamin).
Contact HiSiaddi customer service for more formula optimization consulting services.
Client: PharmaLife B.V., NetherlandsA leading Dutch high-end pharmaceutical and healthcare enterprise specializing in prescription-grade nutritional formulations, premium oral effervescent tablets and sustained-release dietary supplements, supplying major European pharmacy chains, medical institutions and top health brands. The company strictly follows European Pharmacopoeia EP, USP and cGMP standards, prioritizing low impurities and high stability. It is a technology-focused mid-to-high-end client with extremely stringent controls over raw material selection, formula compatibility and production processes, prioritizing product stability and end-product performance over procurement costs.
The client has long sourced domestic pharmaceutical-grade cyanocobalamin (vitamin B12) for mass production of multiple oral solid dosage forms. Following raw material incorporation into production, a series of issues emerged including finished formulation discoloration, active ingredient potency decline, failing dissolution rates and powder agglomeration. The client’s internal R&D team repeatedly adjusted formula ratios, granulation, tableting and storage conditions yet failed to fundamentally resolve the problems, delaying new product launches and reducing production line yield rates. The client subsequently entrusted HiSiaddi with full technical services covering technical diagnosis, root cause analysis, raw material optimization, and matching formula & production process adjustments.
Working alongside technical staff from the raw material manufacturer, HiSiaddi identified four typical application pain points through raw material testing, formula review and production line simulation trials:
1. Finished tablets darken after light-protected storageVitamin B12 is inherently sensitive to light and temperature. The client’s finished tablets and effervescent tablets developed yellow discoloration and uneven color within short-term conventional warehousing, failing European health product appearance quality standards and negatively impacting end-market sales.
2. Sustained decline in active ingredient potencyAfter 30 days under accelerated stability testing (40°C / RH75%), cyanocobalamin potency dropped by over 5%, exceeding the allowable pharmacopoeia deviation range and failing to meet the two-year shelf-life requirement.
3. Powder agglomeration impairs granulation processabilityIncoming raw material powder exhibits poor flowability and readily absorbs moisture to form clumps, leading to uneven dispersion during mixing and wet granulation, causing localized active ingredient enrichment in tablets and excessive inter-tablet potency variation.
4. Low dissolution rates within effervescent systemsWhen incorporated into the client’s proprietary effervescent formula, cyanocobalamin dissolves slowly with a final dissolution rate below 92%, failing European Pharmacopoeia dissolution criteria and resulting in non-conforming finished products.
Comprehensive testing and traceability analysis confirmed the issues stem not from isolated quality defects, but from mismatches between raw material intrinsic properties (impurity composition, surface characteristics), the client’s formula system and production operating conditions:
1. Poor light/thermal stability: Trace residual fermentation proteins and colored impurities remain in the raw material, while powder surfaces lack anti-light protective treatment. Light and high temperatures accelerate cyanocobalamin molecular degradation, triggering discoloration and potency loss.
2. Excessive moisture & hygroscopicity: Elevated free moisture in the raw material and high specific surface area enable rapid moisture absorption from ambient air, leading to agglomeration and clumping, disrupting mixing uniformity.
3. Unfavorable particle morphology: Wide particle size distribution with excessive fine powder impairs overall powder flowability, directly harming granulation uniformity and causing variable tablet weight and potency.
4. Insufficient surface compatibility: Polarity mismatch between cyanocobalamin particle surfaces and organic acid/carbonate components within the effervescent system causes particles to become encapsulated, obstructing water contact and active ingredient release, ultimately depressing dissolution rates.
HiSiaddi adopted a three-in-one solution combining upstream raw material modification, client formula fine-tuning and production process optimization, implemented in stages to preserve existing production line continuity while upgrading product quality.
The manufacturer coordinated targeted optimization of purification and post-treatment processes to address application pain points:
1. Deep impurity removal for enhanced stabilityAdditional multi-stage membrane filtration and decolorization refining fully stripped residual fermentation proteins, polysaccharides and colored impurities. Compliant pharmaceutical-grade light stabilizers (EP-standard, non-toxic) were added at the finished product stage to strengthen molecular resistance to light and heat, slowing degradation rates.
2. Precise moisture control to reduce hygroscopicityVacuum drying parameters were optimized to strictly limit raw material moisture to ≤0.3%, paired with low-temperature dynamic drying to avoid localized overheating and active ingredient breakdown, drastically reducing powder moisture absorption and clumping tendencies.
3. Particle morphology adjustmentCrystallization and sieving processes were revised to narrow particle size distribution and reduce fine powder proportions, improving overall powder flowability and fundamentally mitigating agglomeration.
4. Surface modification treatmentLight coating with pharmaceutical inert excipients adjusted particle surface polarity to boost compatibility with all effervescent formula components, unblocking dissolution pathways.
Adjustment schemes tailored to the physicochemical properties of modified raw materials were issued:
1. Compound anti-oxidant and light-shielding excipientsCompliant pharmaceutical-grade antioxidants and light-blocking excipients were added to the original formula for dual protection, further delaying discoloration and potency loss during finished product storage.
2. Fine-tuning of filler ratiosHigher-flow pharmaceutical excipients were blended to neutralize minor hygroscopicity, supporting improved mixing uniformity and narrower inter-tablet potency deviation.
3. Optimized effervescent component proportionsMinor adjustments to organic acid and carbonate ratios accelerated acid-base reaction rates, coordinating with modified cyanocobalamin to boost dissolution efficiency.
Standard operating specifications were formulated for granulation, tableting and full warehousing workflows:
1. Strict workshop environmental controlMixing and granulation workshops were maintained under constant low-humidity conditions (temperature ≤20°C, relative humidity ≤45%) to minimize raw material moisture uptake.
2. Adjusted feeding and mixing parametersRevised feeding sequences, stirring speeds and mixing durations ensured full homogenization of cyanocobalamin with other excipients to prevent localized accumulation.
3. Standardized finished product storageFinished goods required light-proof hermetic packaging and dedicated constant-temperature storage zones to eliminate light and high-temperature conditions that accelerate ingredient deterioration.
Three sequential small-batch and mass-production validation runs were conducted:
· Round 1 resolved powder agglomeration and uneven mixing issues.
· Round 2 completed stability testing, fully eliminating discoloration and potency decline.
· Round 3 specialized dissolution testing achieved fully compliant specifications.Full test reports were issued for each batch to guarantee batch consistency.
No obvious discoloration observed after long-term finished product storage; potency decline controlled within 1.8% after 30 days of 40°C accelerated testing, meeting pharmacopoeia standards. Powder flowability improved with zero agglomeration or clumping, and inter-tablet potency deviation fell within acceptable limits. Effervescent tablet dissolution rates stabilized above 98%, satisfying all European Pharmacopoeia criteria.
Production line yield rates rose from the original 84% to 99.1%, restoring normal production throughput and enabling new product registration and market launch.
The client recognized HiSiaddi’s professional technical diagnosis and implementation capacity, repositioning the company from a mere supplier to a long-term technical partner. The client maintained consistent procurement of modified cyanocobalamin and entrusted HiSiaddi with application technical support for all additional pharmaceutical vitamin raw materials.
Both parties summarized standardized application protocols for vitamin B12 within oral solid dosage and effervescent tablet systems, serving as a reference for future new product R&D.
For high-end pharmaceutical and healthcare sectors, cyanocobalamin requirements extend far beyond basic indicators such as purity and assay, prioritizing storage stability, processing adaptability and formula compatibility for end-use applications. Conventional raw material manufacturers focus solely on intrinsic physicochemical indicators of their products and lack technical service capabilities for downstream application scenarios, frequently triggering production failures.
Drawing dual technical expertise in chemical engineering and pharmaceuticals, HiSiaddi bridges the full chain covering raw material manufacturing, formula compatibility and end-product production to accurately identify root causes. The integrated "raw material modification + formula adjustment + process optimization" solution resolves all challenges in one stop. For overseas mid-to-high-end clients prioritizing product quality and long-term stability, supporting professional application technical services deliver greater core value than the product itself – this is the key factor enabling HiSiaddi to sustain stable long-term partnerships with premium clients.
Contact HiSiaddi customer service for more formula optimization consulting services.
+86-13120989737 
info@hisiaddi.com 
English
